Merck's Patent On Blockbuster Osteoporosis Drug Fosamax Runs Out

(financialwire.net via COMTEX) -- TEVA | news | PowerRating | PR Charts -- February 6, 2008 (FinancialWire) Merck & Co.'s (NYSE: MRK | news | PowerRating | PR Charts ) patent on its blockbuster osteoporosis drug Fosamax has run out and faces its next big patent expiration in 2010, when the $3 billion-a-year Cozaar/Hyzaar hypertension franchise loses protection.

Generic drugmakers such as Teva Pharmaceuticals (NASDAQ: TEVA | news | PowerRating | PR Charts ) and Barr Pharmaceuticals (NYSE: BRL | news | PowerRating | PR Charts ) will roll out their low-cost versions.

Fosamax sales totaled $3 billion in 2007, but Merck projects that 2008 sales will decline by at least half that, followed by further erosion later on.

Merck is awaiting decisions this year from the Food and Drug Administration on two prospective money-makers: Cordaptive, a cholesterol drug that some analysts consider a potential billion-dollar blockbuster, and taranabant, a diet drug with a more uncertain future because of possible safety issues.

For up-to-the-minute news, features and links click on http://www.FinancialWire.net

FinancialWire is an independent, proprietary news service of Investrend Information, a division of Investrend Communications, Inc. It is not a press release service and receives no compensation from any company for its news or opinions. Other divisions of Investrend, however, provide shareholder empowerment platforms such as forums, independent research and webcasting. For more information or to receive the FirstAlert daily summary of news, commentary, research reports, webcasts, events and conference calls, click on http://www.investrend.com/contact.asp

For a free annual report on a company mentioned in the news, please click on http://investrend.ar.wilink.com/?level=279

To become an investor monitor of independent research for a company in which you are invested, go to the not-for-profit Shareholders Research Alliance, Inc. website by clicking on http://www.shareholdersresearch.com/

The FinancialWire NewsFeed is now available in multiple formats to your site or desktop, free. Click on: http://www.investrend.com/XmlFeeds?level=268

http://www.financialwire.net

Morning Coffee with TradingMarkets -- Free Newsletter

More News:   Market Updates | Stock Alerts | All Trading News | Stock Index